Tagged: Vaccine

COVID-19 vaccines prevent spread of the virus too - Code for life

Grant Jacobs May 13, 2021

Many people seem to be reading that our COVID-19 vaccine won’t prevent the spread of COVID-19 from one person to the next.1 If you’re worried about this, this one is for you. We now have evidence the vaccine reduces transmission, and a rough idea of by how much.2 Science is often about pulling different pieces of evidence together, in this … Read More

Blood clots, vaccines and the need for baselines - Code for life

Grant Jacobs Mar 15, 2021

Some nations are pausing their AstraZeneca COVID-19 vaccine campaigns over concerns that it may be linked to blood clots. International media is is reporting it widely. I’m seeing concerned people asking questions on social media. Evidence so far indicates this is unlikely to be a real issue, but one that is being checked out of caution. One thing it illustrates … Read More

Oxford COVID vaccine authorised in the UK – global health expert on why this is a key moment - COVID-19

Guest Author Jan 05, 2021

Michael Head, University of Southampton The UK has become the first country to authorise the Oxford-AstraZeneca COVID-19 vaccine for public use, with roll-out to start in the first week of 2021. This vaccine is the second to be authorised in the UK – following the Pfizer vaccine. The British government has ordered 100 million doses of the … Read More

A vaccine will be a game-changer for international travel. But it’s not everything - COVID-19

Guest Author Dec 04, 2020

Adrian Esterman, University of South Australia The United Kingdom yesterday became the first country to approve the Pfizer/BioNTech COVID-19 vaccine for widespread use. Following a review by the country’s drug regulator, the UK government announced it will begin rolling out the vaccine next week. Other countries are likely to follow soon, authorising the Pfizer/BioNTech vaccine and possibly other … Read More

How to read results from COVID vaccine trials like a pro - COVID-19

Guest Author Nov 19, 2020

Adrian Esterman, University of South Australia It’s been a busy week or so for news about COVID vaccines. First we heard preliminary clinical trial results from the Pfizer vaccine, then the Russian Sputnik V vaccine. This week, we heard about the Moderna vaccine. All these results were shared with the media, ahead of being peer reviewed and … Read More

Moderna follows Pfizer with exciting vaccine news – how to read these dramatic developments - COVID-19

Guest Author Nov 17, 2020

Simon Kolstoe, University of Portsmouth It is very exciting to hear another positive story about vaccine trial results – a good vaccine is the most likely way of ending the pandemic. Last week, interim results from Pfizer suggested its vaccine reduces cases of COVID-19 with 90% efficacy. Now Moderna has gone one better, with interim results showing nearly … Read More

90% efficacy for Pfizer’s COVID-19 mRNA vaccine is striking. But we need to wait for the full data - COVID-19

Guest Author Nov 12, 2020

Harry Al-Wassiti, Monash University; Colin Pouton, Monash University, and Kylie Quinn, RMIT University German biotech company BioNTech and US pharmaceutical Pfizer announced on Monday promising early results from their phase 3 clinical trial for a vaccine against SARS-CoV-2, the virus that causes COVID-19. These early results are what is known as an “interim analysis”. It’s an early look at the … Read More

Buying a coronavirus vaccine for everyone on Earth, storing and shipping it, and giving it safely will all be hard and expensive - COVID-19

Guest Author Nov 12, 2020

Nicole Hassoun, Binghamton University, State University of New York Infectious diseases do not respect borders. An estimated 3 billion people in low-income countries across Africa, Asia and Latin America are likely to lack access to a COVID-19 vaccine for years after it becomes available. In poor nations, many communities lack the health care workers needed to administer vaccines, … Read More

A new study suggests coronavirus antibodies fade over time – but how concerned should we be? - COVID-19

Guest Author Oct 28, 2020

Sheena Cruickshank, University of Manchester Newly released research suggests that levels of antibodies against the coronavirus have declined across the UK population since testing began. Having randomly sampled 365,000 people across the country, the React2 study – which is yet to be peer-reviewed – estimates that 6% of the UK population had antibodies against the virus … Read More